Neurology Ionis Young Investigator Grant (YIG)
The Neurology Ionis Young Investigator Grant supports early-career research on Angelman Syndrome, fostering scientific advances in diagnosis, disease characterization, and patient care.
Funder: Ionis Pharmaceuticals
Due Dates (Anticipated): May 2027 (full application, projected)
Funding Amounts: Up to $50,000 per year for up to 2 years (total up to $100,000 per awardee; 2 awards annually)
Summary: Supports early-career investigators at academic or non-profit institutions conducting innovative research on Angelman Syndrome.
Key Information: Second year funding contingent on progress; research must be mentored and completed within 2 years.
Description
The Neurology Ionis Young Investigator Grant (YIG) is designed to foster the development of early-career researchers focused on Angelman Syndrome. Funded by Ionis Pharmaceuticals' Neurology division, this grant supports fellows, residents, or junior faculty at academic or non-profit institutions who are engaged in translational, clinical, or applied research. The program aims to advance scientific understanding, improve early diagnosis, characterize disease across age groups, identify undiagnosed or misdiagnosed patients, and enhance patient care in Angelman Syndrome. Each year, up to two investigators are selected for up to two years of funding, with continued support contingent on research progress and impact.
